2026-01-17 - Analysis Report
**Company Overview**
Ventas Inc is a healthcare real estate investment trust (REIT) that provides its clients with investment portfolio management services.

**1. Return Rate Comparison**
- Cumulative return of VTR: 111.05%
- Cumulative return of VOO (S&P 500): 93.36%
- Degree of divergence (simply the difference in cumulative return on the last day of the data): 17.69%

**2. Recent Stock Price Fluctuations**
- Close: $78.45
- Recent price fluctuation (1.99)
- 5-day SMA: $76.97
- 20-day SMA: $77.64
- 60-day SMA: $77.18

**3. RSI, PPO Index Indicators Analysis**
- **Risk Level:** Medium (MRI 0.80)
- **Market Risk Indicator (MRI):** 0.80
- **RSI**: 43.04
- **PPO**: 0.04
- **Expected Return (%)**: -4.00%
- Recent relative divergence change: 3.00 (+): improving, no fluctuation issues

**4. Recent News & Significant Events**
Considering the articles, we notice that:
- A call for Q4 2025 earnings is scheduled.
- Senior housing strength could positively impact the company.
- Stock price falls due to C-Suite stock sales.
- Analysts speculate on the company's potential outperformance.

**Analyst Opinions**
- **Analyst Consensus:** Buy
- **Mean (1=StrongBuy~5=Sell):** 1.52 (~Buy)
- **Opinions:** 20
- **Target Price (avg/high/low):** $85.65 / $94.00 / $75.00

**5. Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-30 | 0.14 | $1.49B |
| 2025-07-31 | 0.15 | $1.42B |
| 2025-05-01 | 0.11 | $1.36B |
| 2024-10-31 | 0.05 | $1.24B |
| 2025-10-30 | 0.05 | $1.24B |

The earnings analysis shows a slight decline in earnings per share (EPS) and fluctuating revenue between $1.36B and $1.49B over the past year.

**6. Financial Information**
### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.49B | 41.58% |
| 2025-06-30 | $1.42B | 41.80% |
| 2025-03-31 | $1.36B | 42.15% |
| 2024-12-31 | $1.29B | 42.42% |
| 2024-09-30 | $1.24B | 42.17% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $12.36B | 0.53% |
| 2025-06-30 | $11.53B | 0.59% |
| 2025-03-31 | $11.47B | 0.41% |
| 2024-12-31 | $10.77B | 0.53% |
| 2024-09-30 | $9.76B | 0.20% |

**7. Comprehensive Analysis (Summary of previous items)**
Key Points:
- VTR stock has outperformed the S&P 500 by a 17.69% margin.
- Recent price fluctuations indicate no sharp rebounds or declines.
- The company has a medium risk profile (MRI 0.80).
- Earnings per share (EPS) decreased while revenue fluctuated.
- Analysts are bullish with a 'Buy' consensus.
- Financial metrics show an increasing equity and profit margin.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.